Skinbase (North America) Limited 12487774 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is the supply of beauty equipment and consumables to beauty salons. Digita Accounts Production Advanced 6.30.9574.0 true 12487774 2024-04-01 2025-03-31 12487774 2025-03-31 12487774 core:RetainedEarningsAccumulatedLosses 2025-03-31 12487774 core:ShareCapital 2025-03-31 12487774 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 12487774 bus:SmallEntities 2024-04-01 2025-03-31 12487774 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 12487774 bus:FilletedAccounts 2024-04-01 2025-03-31 12487774 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12487774 bus:RegisteredOffice 2024-04-01 2025-03-31 12487774 bus:Director1 2024-04-01 2025-03-31 12487774 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12487774 countries:AllCountries 2024-04-01 2025-03-31 12487774 2023-04-01 2024-03-31 12487774 2024-03-31 12487774 core:RetainedEarningsAccumulatedLosses 2024-03-31 12487774 core:ShareCapital 2024-03-31 12487774 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 12487774

Skinbase (North America) Limited Directors' Report and Unaudited Financial Statements for the Year Ended 31 March 2025

Skinbase (North America) Limited

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 4

Skinbase (North America) Limited

Company Information

Director | Mr R M Faulkner

Registered office | C/o Skinbase West Avenue Talke Stoke on Trent ST7 1TL

Accountants | Howsons (Stoke) Limited Winton House Stoke Road Stoke on Trent Staffordshire ST4 2RW

Skinbase (North America) Limited

(Registration number: 12487774)
Balance Sheet as at 31 March 2025

| Note | 2025 £ | 2024 £
Current assets |  |  |
Cash at bank and in hand |  | 3,974 | 12,014
Creditors: Amounts falling due within one year | 4 | (26,536) | (15,882)
Net liabilities |  | (22,562) | (3,868)
Capital and reserves |  |  |
Called up share capital |  | 1 | 1
Retained earnings |  | (22,563) | (3,869)
Shareholders' deficit |  | (22,562) | (3,868)

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006 and in accordance with the provisions of Financial Reporting Standard 102 (FRS 102) Section 1A - small entities.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 17 November 2025

......................................... Mr R M Faulkner Director

Skinbase (North America) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1 | General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
C/o Skinbase
West Avenue
Talke
Stoke on Trent
ST7 1TL

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The company's presentational currency is pound sterling (£). The accounts are rounded to the nearest whole pound.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Skinbase (North America) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Financial instruments

Classification
Basic financial assets, including trade and other debtors, cash and bank balances, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.
Such assets are subsequently carried at amortised cost using the effective interest method.
Basic financial liabilities, including trade and other trade creditors, bank and other loans, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.
Recognition and measurement
At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit and loss.
Impairment
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised in the profit or loss.
Financial assets are derecognised when a) the contractual rights to the cash flows from the asset expire or are settled, or b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

4 | Creditors

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Amounts owed to group undertakings and undertakings in which the company has a participating interest |  | 25,315 | 15,006
Other creditors |  | 1,221 | 876
|  | 26,536 | 15,882